Published in J Pediatr on February 01, 1994
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis (2014) 1.73
Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity. Am J Med Genet C Semin Med Genet (2006) 1.63
Mitochondrial dysfunction in mut methylmalonic acidemia. FASEB J (2008) 1.31
Neurodegeneration and chronic renal failure in methylmalonic aciduria--a pathophysiological approach. J Inherit Metab Dis (2007) 1.22
Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients. Orphanet J Rare Dis (2013) 1.04
Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle. BMC Med Genet (2007) 1.01
Mouse models for methylmalonic aciduria. PLoS One (2012) 0.94
Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia. Hum Gene Ther (2011) 0.93
Differential HMG-CoA lyase expression in human tissues provides clues about 3-hydroxy-3-methylglutaric aciduria. J Inherit Metab Dis (2010) 0.92
Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes. BMC Med Genet (2007) 0.91
Neurological dysfunction in methylmalonic acidaemia is probably related to the inhibitory effect of methylmalonate on brain energy production. J Inherit Metab Dis (1997) 0.91
Chronic pancreatitis in branched-chain organic acidurias--a case of methylmalonic aciduria and an overview of the literature. Eur J Pediatr (2010) 0.84
Acute pancreatitis with rapid clinical improvement in a child with isovaleric acidemia. Case Rep Pediatr (2013) 0.81
Correction of methylmalonic aciduria in vivo using a codon-optimized lentiviral vector. Hum Gene Ther (2014) 0.80
The proteome of methylmalonic acidemia (MMA): the elucidation of altered pathways in patient livers. Mol Biosyst (2016) 0.77
Pancreatitis and organic acidemias. J Pediatr (1995) 0.75
A Rare Cause of Recurrent Acute Pancreatitis in a Child: Isovaleric Acidemia with Novel Mutation. Pediatr Gastroenterol Hepatol Nutr (2017) 0.75
The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med (1990) 4.70
Effect of thymine concentration on the replication velocity of DNA in a thymineless mutant of Escherichia coli. Nature (1970) 4.20
What if pediatric residents could bill for their outpatient services? Pediatrics (2001) 2.74
Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma. J Pediatr (2001) 2.72
Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. American Heart Association. Circulation (1997) 2.68
Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet (1996) 2.65
Synergism of carbenicillin and gentamicin against enterococci. Antimicrob Agents Chemother (1973) 2.60
Changes in cell size and shape associated with changes in the replication time of the chromosome of Escherichia coli. J Bacteriol (1973) 2.56
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet (1992) 2.48
Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet (2001) 2.44
Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet (1992) 2.41
Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group. Arch Dis Child (1999) 2.39
Functional, biochemical and genetic diversity of prokaryotic nitrate reductases. Cell Mol Life Sci (2001) 2.34
Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed (2000) 2.24
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24
Ultrastructural and biochemical changes in human jejunal mucosa associated with enteropathogenic Escherichia coli (0111) infection. J Pediatr Gastroenterol Nutr (1986) 2.21
Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med (1998) 2.20
Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess (1997) 2.20
Comparative pharmacokinetics of amikacin and kanamycin. Clin Pharmacol Ther (1974) 2.15
Elongation of rod-shaped bacteria. J Theor Biol (1977) 2.15
HLA-DRB1 and multiple sclerosis in Malta. Neurology (2007) 2.14
Clinical and laboratory findings in referrals for mitochondrial DNA analysis. Arch Dis Child (1998) 2.12
Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics (1996) 2.08
Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 2.07
Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus. J Infect Dis (1975) 1.94
Role of early fluid resuscitation in pediatric septic shock. JAMA (1991) 1.90
Bacteriophage T4 development depends on the physiology of its host Escherichia coli. Microbiology (1997) 1.90
Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis (2009) 1.89
Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology (1999) 1.88
Hyperinsulinaemic hypoglycaemia in small for dates babies. Arch Dis Child (1990) 1.86
Replication time of the chromosome in thymineless mutants of Escherichia coli. J Mol Biol (1971) 1.82
Role of the nucleoid in the toporegulation of division. Res Microbiol (1990) 1.81
Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. N Engl J Med (1990) 1.78
Dilated cardiomyopathy with neutropenia, short stature, and abnormal carnitine metabolism. J Pediatr (1988) 1.76
Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology (1988) 1.75
Open access exercise electrocardiography: a service to improve management of ischaemic heart disease by general practitioners. J R Soc Med (1991) 1.73
Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol. Br Med J (1977) 1.71
Cardiomyopathy in propionic acidaemia. Eur J Pediatr (1993) 1.70
Postanesthetic apnea in full-term infants after pyloromyotomy. Anesthesiology (1994) 1.67
Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. N Engl J Med (1985) 1.67
DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet (1989) 1.66
Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr (1982) 1.64
Noninvasive ventilation via bilevel positive airway pressure support in pediatric practice. Crit Care Med (1998) 1.61
On microbial states of growth. Mol Microbiol (1995) 1.60
Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Members of the Mid-Atlantic Pediatric Critical Care Network. Crit Care Med (1999) 1.59
Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med (1996) 1.59
Copper-histidine therapy for Menkes disease. J Pediatr (1993) 1.56
Measurement of membrane potential in Bacillus subtilis: a comparison of lipophilic cations, rubidium ion, and a cyanine dye as probes. J Membr Biol (1981) 1.56
Extended screening by PCR for seven cry-group genes from field-collected strains of Bacillus thuringiensis. Appl Environ Microbiol (1997) 1.56
Hyperinsulinism in asphyxiated and small-for-dates infants with hypoglycaemia. Lancet (1984) 1.55
The early detection and management of inborn errors presenting acutely in the neonatal period. Eur J Pediatr (1985) 1.53
Regional variations in medium-chain acyl-CoA dehydrogenase deficiency. Lancet (1995) 1.52
Movement disorder after withdrawal of fentanyl infusion. J Pediatr (1991) 1.52
Diagnostic value of succinate ubiquinone reductase activity in the identification of patients with mitochondrial DNA depletion. J Inherit Metab Dis (2002) 1.51
Contribution of aminoacid catabolism to propionate production in methylmalonic acidaemia. Lancet (1989) 1.50
The use of symptoms to predict colorectal cancer site. Can we reduce the pressure on our endoscopy services? Colorectal Dis (2009) 1.50
Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood. Arch Dis Child (1992) 1.49
Automatic construction of eigenshape models by direct optimization. Med Image Anal (1998) 1.49
On dimensional determination of rod-shaped bacteria. J Theor Biol (1975) 1.48
Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene? Clin Genet (2009) 1.47
Obstacles to timely neonatal screening in North Thames. J Med Screen (1998) 1.47
An objective staging for cortical cataract in vivo aided by pattern-analysing computer. Exp Eye Res (1981) 1.46
Hypoalbuminemia at initial examination in patients with cystic fibrosis. J Pediatr (1989) 1.45
Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut (2003) 1.45
Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK. Arch Dis Child (1998) 1.45
Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease. Am J Hum Genet (1991) 1.44
Preparation and properties of brush-border membrane vesicles from human small intestine. Gastroenterology (1990) 1.44
Intestinal disease in cystic fibrosis. Arch Dis Child (1988) 1.43
Fibrosing colonopathy in a child on low-dose pancreatin. Lancet (1995) 1.43
Constant peptidoglycan density in the sacculus of Escherichia coli B/r growing at different rates. FEBS Lett (1979) 1.42
Treatment pathways for patients with atrial fibrillation. Int J Clin Pract (2012) 1.42
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex. J Pediatr (1987) 1.41
Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr (2000) 1.41
Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet (1999) 1.41
The genetic heterogeneity of lactic acidosis: occurrence of recognizable inborn errors of metabolism in pediatric population with lactic acidosis. Pediatr Res (1980) 1.41
Factitious diarrhea: a case of watery deception. J Pediatr Gastroenterol Nutr (2001) 1.40
Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest (1996) 1.40
Hypoglycaemia complicating feeding regimens for glycogen-storage disease. Lancet (1978) 1.39
A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype. J Pediatr (1998) 1.39
Biotinidase deficiency: early neurological presentation. Dev Med Child Neurol (1994) 1.39
Chronic varioliform gastritis in childhood. J Pediatr (1989) 1.39
Partial biotinidase deficiency associated with Coffin-Siris syndrome. Eur J Pediatr (1990) 1.39
Bending and fracture of the femoral component in cemented total hip replacement. J Biomed Eng (1992) 1.39
A simple method for the maintenance of oxygen saturation following intravenous induction of anaesthesia with propofol. Anaesthesia (1994) 1.39
Evaluation of a pediatric intensive care residency curriculum. Crit Care Med (1997) 1.39
The conversion of phenylalanine to tyrosine in man. Direct measurement by continuous intravenous tracer infusions of L-[ring-2H5]phenylalanine and L-[1-13C] tyrosine in the postabsorptive state. Metabolism (1982) 1.38
Enzyme replacement therapy by renal allotransplantation in Fabry's disease. N Engl J Med (1972) 1.38
How reliable is the allopurinol load in detecting carriers for ornithine transcarbamylase deficiency? J Inherit Metab Dis (2004) 1.38
Control of microbial surface-growth by density. Nature (1978) 1.37
Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr (1989) 1.37
Ticarcillin vs carbenicillin: clinical pharmacokinetics. Clin Pharmacol Ther (1975) 1.37
Gastroesophageal reflux and esophagitis-associated hypertrophic osteoarthropathy. J Pediatr Gastroenterol Nutr (1996) 1.36
Neurological implications of urea cycle disorders. J Inherit Metab Dis (2007) 1.36
Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol (1993) 1.35
Surface growth in rod-shaped bacteria. J Theor Biol (1978) 1.35
Causes of and diagnostic approach to methylmalonic acidurias. J Inherit Metab Dis (2008) 1.34
Dimensional rearrangement of rod-shaped bacteria following nutritional shift-up. II. Experiments with Escherichia coli B/r. J Theor Biol (1980) 1.33